Patent ID: 11866505
Assignee: PROMETHEUS BIOSCIENCES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The antibody or antigen binding fragment thereof of claim 1, wherein the CDR-H1 comprises the amino acid sequence set forth in SEQ ID NO: 115, the CDR-H2 comprises the amino acid sequence set forth in SEQ ID NO: 155, the CDR-H3 comprises the amino acid sequence set forth in SEQ ID NO: 195, the CDR-L1 comprises the amino acid sequence set forth in SEQ ID NO: 315, the CDR-L2 comprises the amino acid sequence set forth in SEQ ID NO: 355, and the CDR-L3 comprises the amino acid sequence set forth in SEQ ID NO: 395.